Delivery Order SPE2DB24D1104-SPE2DB24FXZP6
Award Date
6/24/24
Potential Completion Date
6/25/24
Potential Value
$25K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of STELARA 90 MG/ML syringes to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, through its Corporate Office Division. This is a firm fixed-price delivery order contract with a ceiling value of $47,003.95 and an ultimate completion date of April 23, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award is for the delivery of STELARA 90 MG/ML syringes to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract, valued at $14,751.06, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and supplier to federal agencies. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued up to $999,999,999.00 through December 31, 2025. This...
This federal contract award is for the delivery of STELARA 90 MG/ML syringes to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $26,692.61 and runs through May 31, 2024. It is a Firm Fixed Price Delivery Order contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award is for the delivery of STELARA 90 MG/ML SYRINGEML to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract was awarded to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on a firm-fixed price basis. The contract has a ceiling value of $6,715.70 and an ultimate completion date of April 25, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC)...
The federal contract award is for the delivery of STELARA 90 MG/ML SYRINGEML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $25,839.68 and is a delivery order awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price arrangement with an ultimate completion date of December 6, 2024. This award is not associated with a set-aside...
This federal contract award is for the delivery of STELARA 90 MG/ML SYRINGEML, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The award, valued at $7,956.68, was granted on July 3, 2024 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with a completion date of July 5, 2024. The contract is a Delivery Order under a Firm Fixed Price pricing type. This award is associated with Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with...
This federal contract award is for the delivery of Stelara 90 mg/ml syringes to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a ceiling value of $18,669.37. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC is valued at up to $999,999,999.00 and runs through November 2026,...
This contract award is for the delivery of Stelara 90 mg/ml syringes to the Defense Logistics Agency (DLA), a defense agency. The contract has a total ceiling value of $31,753.82 and runs through December 31, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This award is a delivery order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and running through...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of STELARA 90 MG/ML SYRINGEML medical products. The $18,460.64 fixed-price delivery order was awarded by the Defense Logistics Agency (DLA), a defense agency that supports the military's healthcare needs. The contract has an ultimate completion date of December 3, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...
This federal contract award is for the delivery of Stelara 90 mg/ml syringes to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and has a ceiling value of $18,689.24. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC is valued at up to $999,999,999.00 and runs...